Most noticeably, the clonogenic capacity of cells co-treated with TrxR1 overexpression and TIGAR abrogation was substantially lower than that of control cells, indicating a significant radiosensitization of TrxR1-overexpressing glioma cells. This evidence concerns the gene TIGAR and central nervous system cancer.